Allianz Asset Management’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-37,900
Closed -$3.81M 2471
2014
Q4
$3.81M Sell
37,900
-336,985
-90% -$26.2M ﹤0.01% 1313
2014
Q3
$24.7M Buy
374,885
+121,994
+48% +$8.01M 0.03% 575
2014
Q2
$17.7M Buy
252,891
+14,090
+6% +$958K 0.02% 597
2014
Q1
$17.3M Buy
238,801
+44,441
+23% +$3.31M 0.02% 591
2013
Q4
$13.4M Buy
194,360
+30,640
+19% +$1.98M 0.02% 631
2013
Q3
$10.4M Buy
163,720
+16,420
+11% +$992K 0.01% 654
2013
Q2
$7.11M Buy
+147,300
New +$7.24M 0.01% 753

Allianz Asset Management's CBST Position: Q1 2015 in Review

Allianz Asset Management sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q1 2015, closing a stake of 37,900 shares — an estimated $3.81M sold.

Allianz Asset Management first reported a position in CBST in Q2 2013 and held it in 7 quarters. The position peaked at $24.7M in Q3 2014. 0 funds tracked by Wall St. Rank hold CBST as of Q1 2015.

  • Allianz Asset Management reported no remaining CUBIST PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • Allianz Asset Management sold 37,900 CUBIST PHARMACEUTICALS INC shares in Q1 2015, an estimated $3.81M.
  • Allianz Asset Management first reported a position in CUBIST PHARMACEUTICALS INC in Q2 2013 and held it in 7 quarters.
  • Allianz Asset Management's CUBIST PHARMACEUTICALS INC position peaked at $24.7M in Q3 2014.
  • 0 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q1 2015.

Based on Allianz Asset Management's 13F filing for Q1 2015, filed 15 May 2015.